Key statistics
As of last trade, IQVIA Holdings Inc (IQV:NYQ) traded at 172.02, 27.76% above the 52 week low of 134.65 set on May 23, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 170.79 |
|---|---|
| High | 172.99 |
| Low | 168.53 |
| Bid | 171.96 |
| Offer | 172.12 |
| Previous close | 174.27 |
| Average volume | 3.15m |
|---|---|
| Shares outstanding | 167.87m |
| Free float | 166.71m |
| P/E (TTM) | 22.17 |
| Market cap | 29.25bn USD |
| EPS (TTM) | 7.86 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 17:56 GMT.
More ▼
- IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference
- IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference
- IQVIA Releases its 2025 Sustainability Report
- IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities
- IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day
- IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions
- IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance
- IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration
- IQVIA Named to the Fortune® World’s Most Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year
- IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026
More ▼
